




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Invasive Cardiovascular Angiography and Intervention</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2d1edb86-1b6a-4771-8577-42769c4272ef</link>
        <description>Clinical Topic Feed: Invasive Cardiovascular Angiography and Intervention</description>
        <language>en</language>

        

                <item>
                    <title>Interventional Post-ACS Antithrombotic Trials at ESC Congress 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/10/16/17/49/Trials-at-ESC</link>                    <description>Four late-breaking trials, presented at ESC Congress 2026 focused on post-acute coronary syndrome (ACS) antithrombotic therapy.</description>
                    <pubdate>1792177140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Structural Heart Disease Trials Featured at ESC Congress 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/10/16/16/15/Structural-Heart-Disease-Trials-Featured-at-ESC-Congress-2026</link>                    <description>Four late-breaking trials presented at ESC Congress 2026 offer new insights into the management of structural heart disease and heart failure (HF).</description>
                    <pubdate>1792168860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Emerging Evidence: Refractory Angina and Coronary Sinus Reducers</title>
<link>/Latest-in-Cardiology/Articles/2026/10/14/12/36/Emerging-Evidence</link>                    <description>Refractory angina (RA) is an increasing global cardiovascular challenge, affecting approximately 10-15% of patients with coronary artery disease (CAD). RA is defined as persistent anginal symptoms (&#226;‰&#165;3 months) due to myocardial ischemia despite guideline-directed medical therapy...</description>
                    <pubdate>1791999300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PREVENT Analysis: Preventive PCI Lowers CV Risk in Patients With Lipid-Rich Plaques</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/14/09/58/PREVENT-Analysis</link>                    <description>In patients with lipid-rich plaques (LRPs) defined by near-infrared spectroscopy (NIRS), preventive PCI was associated with lower cardiovascular risk, yet no significant association was observed in patients with non-LRPs despite their large plaque burden and small minimal lumen area...</description>
                    <pubdate>1791996180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Sex Disparities in CV Trials; Left Stellate Ganglion Blocks &amp; CABG; Bifurcation Lesions; Managing Resistant Hypertension</title>
<link>/Latest-in-Cardiology/Articles/2026/10/14/12/36/eagles-eye-view-14oct2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at continued sex disparities in CV clinical trials.&#226;€&#175;He then examines how preemptive left stellate ganglion block (SGB) is associated with a reduced incidence of postoperative atrial fibrillation (POAF) in patients undergoing CABG.</description>
                    <pubdate>1791994020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AMUNDSEN: Does Early Evolocumab Improve Outcomes in Acute MI?</title>
<link>/Latest-in-Cardiology/Articles/2026/10/09/15/06/AMUNDSEN</link>                    <description>Lipid lowering after acute myocardial infarction (MI) is central to secondary prevention, but stepwise therapy may delay LDL-C target attainment. The AMUNDSEN trial, presented at ESC Congress 2026 and simultaneously published in JAMA, assessed whether pre-PCI evolocumab could accelerate LDL-C reduction and improve clinical outcomes.</description>
                    <pubdate>1791903300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: What Clinicians May Be Missing: Overcoming Barriers to Aortic Stenosis Diagnosis</title>
<link>/Latest-in-Cardiology/Articles/2026/10/09/15/06/cardiacast_09oct2026</link>                    <description>This episode is part of ACC&#226;€™s ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis.&#226;€&#175;Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis.</description>
                    <pubdate>1791558780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Stellate Ganglion Block Reduces POAF After CABG</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Stellate-Ganglion-Block</link>                    <description>Preemptive left stellate ganglion block (SGB) was associated with a reduced incidence of postoperative atrial fibrillation (POAF) within five postoperative days in patients undergoing CABG with cardiopulmonary bypass, according to results from a prospective controlled trial published Sept. 29 in JACC: Clinical Electrophysiology.</description>
                    <pubdate>1791378000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>OCTOBER Analysis: 1-Stent vs. 2-Stent PCI in True Bifurcation Lesions</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/OCTOBER-Analysis</link>                    <description>In patients with true bifurcation lesions, clinical indication, left main coronary artery (LMCA) bifurcation and side branch (SB) disease severity were the strongest predictors of two-stent PCI, while optical coherence tomographic (OCT)-guided one-stent PCI was associated with the lowest risk for major adverse cardiovascular events...</description>
                    <pubdate>1791378000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SUBLIME: LIRA Method Effective, Safe and Reproducible For TAVR Patients With BAV</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/13/56/SUBLIME</link>                    <description>A TAVR sizing method for bicuspid aortic valve (BAV) anatomy using the level of implantation at the raphe (LIRA) approach demonstrated favorable procedural and clinical outcomes and good reproducibility across centers, according to results from the SUBLIME study published Sept. 28 in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1791303120000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>